These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6875821)

  • 1. Synthesis, isolation, and characterization of two stereoisomeric ring sulfoxides of thioridazine.
    Juenge EC; Wells CE; Green DE; Forrest IS; Shoolery JN
    J Pharm Sci; 1983 Jun; 72(6):617-21. PubMed ID: 6875821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat.
    Watkins GM; Whelpton R; Buckley DG; Curry SH
    J Pharm Pharmacol; 1986 Jul; 38(7):506-9. PubMed ID: 2875150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convenient oxidation of phenothiazine salts to their sulfoxides with aqueous nitrous acid.
    Owens ML; Juenge EC; Poklis A
    J Pharm Sci; 1989 Apr; 78(4):334-6. PubMed ID: 2724098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration.
    Hale PW; Poklis A
    J Anal Toxicol; 1985; 9(5):197-201. PubMed ID: 4057956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC resolution of thioridazine enantiomers from pharmaceutical dosage form using cyclodextrin-based chiral stationary phase.
    Bhushan R; Gupta D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):133-7. PubMed ID: 16675310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides.
    Poklis A; Wells CE; Juenge EC
    J Anal Toxicol; 1982; 6(5):250-2. PubMed ID: 7176556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of diastereoisomeric pairs of thioridazine 5-sulfoxide by high-performance liquid chromatography.
    Hale PW; Poklis A
    J Chromatogr; 1984 Dec; 336(2):452-5. PubMed ID: 6530479
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical characterization of decomposition products of drugs. Part 5: Products of autoxidation and photo-oxidation of thioridazine hydrochloride.
    Pawelczyk E; Marciniec B
    Pharmazie; 1974 Sep; 29(9):585-5. PubMed ID: 4421012
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.
    Eap CB; Koeb L; Powell K; Baumann P
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):271-9. PubMed ID: 7581903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
    Hale PW; Poklis A
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The S-oxidative degradation of a novel corticosteroid tipredane (INN) Part III. Detailed investigations into the disulphoxidation of tipredane.
    Euerby MR; Graham JA; Johnson CM; Lewis RJ; Wallace DB
    J Pharm Biomed Anal; 1996 Dec; 15(3):299-313. PubMed ID: 8951690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation and configurational changes of thioridazine 2-sulfoxide.
    de Gaitani CM; Martinez AS; Bonato PS
    J Pharm Biomed Anal; 2004 Nov; 36(3):601-7. PubMed ID: 15522536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat.
    Hale PW; Melethil S; Poklis A
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):333-41. PubMed ID: 3830721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of the absolute configuration at the sulfur atom of thioridazine metabolites by the analysis of their chiroptical properties: the case of thioridazine 2-sulfoxide.
    Bertucci C; Guimarães LF; Bonato PS; Borges KB; Okano LT; Mazzeo G; Rosini C
    J Pharm Biomed Anal; 2010 Sep; 52(5):796-801. PubMed ID: 20376912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of phenothiazine derivatives to the corresponding sulphoxides on thin-layer plates.
    Kofoed J; Korczak-Fabierkiewicz C; Lucas GH
    Nature; 1966 Jul; 211(5045):147-50. PubMed ID: 5965512
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of liquid-liquid systems for the chromatographic separation of the psychotropic thioridazine and it's metabolites.
    Muusze RG; Huber JF
    J Chromatogr; 1973 Aug; 83():405-20. PubMed ID: 4147446
    [No Abstract]   [Full Text] [Related]  

  • 19. High-performance liquid chromatographic resolution of the enantiomers of thioridazine, its metabolites and related compounds.
    Whelpton R; Jonas G; Buckley DG
    J Chromatogr; 1988 Apr; 426(1):223-8. PubMed ID: 3384875
    [No Abstract]   [Full Text] [Related]  

  • 20. Racemization and degradation of thioridazine and thioridazine 2-sulfone in human plasma and aqueous solutions.
    Masetto de Gaitani C; Martinez AS; Bonato PS
    Chirality; 2003 Jun; 15(6):479-85. PubMed ID: 12774286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.